Items where authors include "Chodick, G."

Article

Moser, S.S., Apter, L., Solomon, J. orcid.org/0000-0003-1022-5759 et al. (3 more authors) (2024) Time on treatment and survival outcomes for patients treated with first-line osimertinib vs. other tyrosine kinase inhibitors, for EGFR mutation-positive metastatic non-small cell lung cancer: real-world experience data. Anticancer Research, 44 (1). pp. 257-265. ISSN 0250-7005

Sharman Moser, S. orcid.org/0000-0002-9745-2016, Tanser, F., Siegelmann-Danieli, N. et al. (3 more authors) (2023) The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer. Journal of Pharmaceutical Policy and Practice, 16 (1). 22. ISSN 2052-3211